GSTT1 and GSTM1 polymorphisms and prostate cancer risk in Asians: A systematic review and meta-analysis

Tumor Biology

Volumn 34, Issue 5, 2013, Pages 2539-2544

  Liu, Dajun ^a   Liu, Ying ^b   Ran, Limei ^c   Shang, Huiping ^a   Li, Detian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Key Laboratory of Boron Resources Ecological Utilization Technology and Boron Material   (China)

^c GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

GSTM1; GSTT1; Polymorphisms; Prostate cancer

Indexed keywords

GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; ENZYMOLOGY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; META ANALYSIS; PROSTATE TUMOR; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84885419887     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0778-z     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Green SM, Mostaghel EA, Nelson PS. Androgen action and metabolism in prostate cancer. Mol Cell Endocrinol. 2012;360:3-13.
3. Amankwah EK, Sellers TA, Park JY. Gene variants in the angiogenesis pathway and prostate cancer. Carcinogenesis. 2012;33:1259-69.
4. Pan DL, Samavedi S, Eldefrawy A, Manoharan M. The current status of active surveillance for prostate cancer. Postgrad Med. 2012;124:50-8.
5. Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S- transferase family of enzymes. Mutat Res. 2001;482:21-6.
6. Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi YC. Antioxidant role of glutathione s-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid Redox Signal. 2004;6:289-300.
7. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51-88.
8. Oakley A. Glutathione transferases: a structural perspective. Drug Metab Rev. 2011;43:138-51.
9. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61:154-66.
10. Murata M, Watanabe M, Yamanaka M, Kubota Y, Ito H, Nagao M, et al. Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett. 2001;165:171-7.
11. Nakazato H, Suzuki K, Matsui H, Koike H, Okugi H, Ohtake N, et al. Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population. Anticancer Res. 2003;23:2897-902.
12. Mittal RD, Srivastava DS, Mandhani A, Kumar A, Mittal B. Polymorphism of GSTM1 and GSTT1 genes in prostate cancer: a study from North India. Indian J Cancer. 2004;41:115-9.
13. Komiya Y, Tsukino H, Nakao H, Kuroda Y, Imai H, Katoh T. Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population. J Cancer Res Clin Oncol. 2005;131:238-42.
14. Srivastava DS, Mandhani A, Mittal B, Mittal RD. Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India. BJU Int. 2005;95:170-3.
15. Vijayalakshmi K, Vettriselvi V, Krishnan M, Shroff S, Vishwanathan KN, Jayanth VR, et al. Polymorphisms at GSTM1 and GSTP1 gene loci and risk of prostate cancer in a South Indian population. Asian Pac J Cancer Prev. 2005;6:309-14.
16. Mittal RD, Mishra DK, Mandhani A. Evaluating polymorphic status of glutathione-S-transferase genes in blood and tissue samples of prostate cancer patients. Asian Pac J Cancer Prev. 2006;7:444-6.
17. Yang J, Wu HF, Zhang W, Gu M, Hua LX, Sui YG, et al. Polymorphisms of metabolic enzyme genes, living habits and prostate cancer susceptibility. Front Biosci. 2006;11:2052-60.
18. Kumar V, Yadav CS, Datta SK, Singh S, Ahmed RS, Goel S, et al. Association of GSTM1 and GSTT1 polymorphism with lipid peroxidation in benign prostate hyperplasia and prostate cancer: a pilot study. Dis Markers. 2011;30:163-9.
19. Choubey VK, Sankhwar SN, Tewari R, Sankhwar P, Singh BP, Rajender S. Null genotypes at the GSTM1 and GSTT1 genes and the risk of benign prostatic hyperplasia: a case-control study and a meta-analysis. Prostate. 2013;73:146-52.
20. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101-29.
21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
22. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
23. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
24. Guan TY, Li M, Na YQ. [Polymorphism of metabolic gene and genetic susceptibility to prostate cancer]. Zhonghua Wai Ke Za Zhi. 2005;43:1467-70.
25. Wang YL, Jiang J, Wang LF, Liu YF. Polymorphisms of glutathione-S- transferase genes GSTM1 and GSTT1 and prostate cancer risk in Chinese population. Acta Academiae Medicinae Militaris Tertiae. 2005;27:1039-41.
26. Li M, Guan TY, Li Y, Na YQ. Polymorphisms of GSTM1 and CYP1A1 genes and their genetic susceptibility to prostate cancer in Chinese men. Chin Med J (Engl). 2008;121:305-8.
27. Ansari SB, Vasudevan R, Bakhshi A, Mirinargesi M, Patimah I, Sabariah AR, et al. Analysis of glutathione S-transferase (M1, T1 and P1) gene polymorphisms in Iranian prostate cancer subjects. Afr J Biotechnol. 2010;9:7230-5.
28. Ashtiani ZO, Hasheminasab SM, Ayati M, Goulian BS, Modarressi MH. Are GSTM1, GSTT1 and CAG repeat length of androgen receptor gene polymorphisms associated with risk of prostate cancer in Iranian patients? Pathol Oncol Res. 2011;17:269-75.
29. Kwon DD, Lee JW, Han DY, Seo IY, Park SC, Jeong HJ, et al. Relationship between the glutathione-S-transferase P1, M1, and T1 genotypes and prostate cancer risk in Korean subjects. Korean J Urol. 2011;52:247-52.
30. Safarinejad MR, Shafiei N, Safarinejad SH. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran. Prostate Cancer Prostatic Dis. 2011;14:105-13.
31. Thakur H, Gupta L, Sobti RC, Janmeja AK, Seth A, Singh SK. Association of GSTM1T1 genes with COPD and prostate cancer in north Indian population. Mol Biol Rep. 2011;38:1733-9.
32. Galsky MD, Small AC, Tsao CK, Oh WK. Clinical development of novel therapeutics for castration-resistant prostate cancer: historic challenges and recent successes. CA Cancer J Clin. 2012;62:299-308.
33. Tammela TL. Endocrine prevention and treatment of prostate cancer. Mol Cell Endocrinol. 2012;360:59-67.
34. Economopoulos KP, Sergentanis TN, Vlahos NF. Glutathione S-transferase M1, T1, and P1 polymorphisms and ovarian cancer risk: a meta-analysis. Int J Gynecol Cancer. 2010;20:732-7.
35. Gao LB, Pan XM, Li LJ, Liang WB, Bai P, Rao L, et al. Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: an evidence-based meta-analysis. PLoS One. 2011;6:e20157.
36. Zhang ZJ, Hao K, Shi R, Zhao G, Jiang GX, Song Y, et al. Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: a huge review and meta-analysis. Am J Epidemiol. 2011;173:847-57.
37. Song K, Yi J, Shen X, Cai Y. Genetic polymorphisms of glutathione S-transferase genes GSTM1, GSTT1 and risk of hepatocellular carcinoma. PLoS One. 2012;7:e48924.
38. Wang D, Zhang LM, Zhai JX, Liu DW. GSTM1 and GSTT1 polymorphisms and colorectal cancer risk in Chinese population: a meta-analysis. Int J Colorectal Dis. 2012;27:901-9.
39. Wang B, Huang G, Wang D, Li A, Xu Z, Dong R, et al. Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol. 2010;53:508-18.